Clinical Trial: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult Subjects

U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07324434) titled 'A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult Subjects' on Nov. 28, 2025.

Brief Summary: The primary objective of this study is to evaluate the safety, tolerability and pharmacokinetic (PK) profiles of ascending single orally administered doses of F-02-2-Na in adult subjects (to include the Mass Balance) & multiple orally administered doses of F-02-2-Na in adult subjects with Hyperuricemia.

Study Start Date: Dec. 15, 2025

Study Type: INTERVENTIONAL

Condition: Hyperuricemia With or Without Gout

Intervention: DRUG: F-02-2-Na Tablet (0.5 mg)

The intervention involves the sing...